Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Acadia Pharmaceuticals Inc (ACAD)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Great Point Partners

Jeffrey Jay And David Kroin

2,000,000 $30,540 4.31%
2.
Baker Bros. Advisors

Julian Baker And Felix Baker

27,228,338 $415,777 3.12%
3.
Ghost Tree Capital

Ken Greenberg And David Kim

535,000 $8,169 +34% 2.4%
4.
Palo Alto Investors

William Leland Edwards

1,650,780 $25,207 1%
5.
OrbiMed Advisors

Samuel Isaly

4,282,400 $65,392 +29% 0.77%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$22.52 3,000 10,000 2018-03-02 Filing
$24.52 2,000 7,000 2018-03-01 Filing
$24.09 3,000 5,000 2018-03-01 Filing
$23.02 2,000 2,000 2018-03-01 Filing
$32.97 1,000 1,000 2016-08-16 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$32.39 36,558 83,734 2018-01-29 Filing
$30.14 74,321 70,113 2018-01-02 Filing
$30.06 25,000 0 2018-01-02 Filing
$40.91 37,500 69,656 2017-10-05 Filing
$34.87 26,507 67,656 2017-08-30 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 264,760 $4,043 2%
2. 194,900 $2,976 1.8%
3. 144,125 $2,201 1.46%
4. 53,500 $817 0.66%
5. 184,510 $2,817 0.37%
News See All